Almirall Overview
- Year Founded
-
1944
- Status
-
Public
- Employees
-
2,097
- Stock Symbol
-
ALM
- Investments
-
16
- Share Price
-
$11.80
- (As of Friday Closing)
Almirall General Information
Description
Almirall SA is a skin-health focused pharmaceutical company based in Barcelona and the parent company of a group engaged in the purchase, manufacture, storage, marketing, and mediation in the sale of pharmaceutical specialities and products, as well as related raw materials. The Group applies science to provide medical solutions focused on skin health diseases and partners with healthcare professionals, and its activities also include cosmetics; chemical, biotechnological and diagnostic products for human, veterinary, agrochemical and food use; instruments and accessories for the chemical, pharmaceutical and clinical industry; and research on active chemical and pharmaceutical ingredients and products.
Contact Information
Website
www.almirall.comCorporate Office
- Ronda General Mitre, 151
- 08022 Barcelona
- Spain
Corporate Office
- Ronda General Mitre, 151
- 08022 Barcelona
- Spain
Almirall Timeline
Almirall Stock Performance
As of 13-Nov-2026, Almirall’s stock price is $11.80. Its current market cap is $2.57B with 218M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $11.80 | $11.96 | $10.95 - $16.48 | $2.57B | 218M | 137K | $0.39 |
Almirall Financials Summary
As of 30-Jun-2026, Almirall has a trailing 12-month revenue of $1.65B.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 2,768,614 | 3,189,876 | 1,831,129 | 2,066,665 |
| Revenue | 1,645,479 | 1,249,926 | 1,066,648 | 967,934 |
| EBITDA | 322,293 | 256,221 | 180,291 | 117,674 |
| Net Income | 83,581 | 52,062 | 10,980 | (41,632) |
| Total Assets | 2,702,943 | 2,745,242 | 2,493,900 | 2,625,308 |
| Total Debt | 406,634 | 402,729 | 425,397 | 445,748 |
Almirall Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Almirall Comparisons
Industry
Financing
Details
Almirall Competitors (35)
One of Almirall’s 35 competitors is Evonile Pharma, a Private Equity-Backed company based in Mumbai, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Evonile Pharma | Private Equity-Backed | Mumbai, India | ||||
| Assertio Holdings | Formerly VC-backed | Lake Forest, IL | ||||
| Chiesi Farmaceutici | Private Debt Financed | Parma, Italy | ||||
| Grifols | Corporation | Barcelona, Spain | ||||
| GSK | Corporation | London, United Kingdom |
Almirall Patents
Almirall Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026215234-A1 | Heterocyclic compounds which bind to stat6 | Pending | 08-Apr-2025 | ||
| WO-2026215237-A1 | Heterocyclic derivative and use thereof | Pending | 08-Apr-2025 | ||
| WO-2026057795-A1 | Dispenser | Pending | 13-Sep-2024 | ||
| WO-2026022232-A1 | Il-1rap inhibitor for treating or preventing hidradenitis suppurativa | Pending | 24-Jul-2024 | ||
| WO-2026022219-A1 | Injectable formulations comprising tirbanibulin | Pending | 24-Jul-2024 | A61K9/0019 |
Almirall Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Almirall Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Almirall Investments & Acquisitions (16)
Almirall’s most recent deal was a Corporate Asset Purchase with Eloxx Pharmaceuticals (ZKN-013 License) for . The deal was made on 11-Mar-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals (ZKN-013 License) | 11-Mar-2024 | Corporate Asset Purchase | Buildings and Property | ||
| DFT El Globo (Physiorelax) | 03-Feb-2023 | Corporate Asset Purchase | Buildings and Property | ||
| Bioniz Therapeutics | 25-Jan-2020 | Merger/Acquisition | Drug Delivery | ||
| Allergan (five dermatology brands) | 21-Sep-2018 | Corporate Asset Purchase | Buildings and Property | ||
| ThermiGen | 09-Feb-2016 | Merger/Acquisition | Therapeutic Devices |
Almirall ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
16.55 | Low Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Pharmaceuticals
Industry
of 852
Rank
Percentile
Pharmaceuticals
Subindustry
of 354
Rank
Percentile
Almirall Exits (7)
Almirall’s most recent exit was on 25-Jan-2020 from Bioniz Therapeutics. The exit was categorized as .
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Bioniz Therapeutics | 25-Jan-2020 | Completed |
|
||
| ThermiGen | 09-Feb-2016 | Completed |
|
||
| ThermiGen | 01-Sep-2015 | Completed |
|
||
| Suneva Medical | 29-Jul-2015 | Completed |
|
||
| AB-Biotics | 19-Dec-2012 | PIPE | Completed |
|
Almirall Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Almirall Digital Garden | Barcelona, Spain | 2020 |
Almirall FAQs
-
When was Almirall founded?
Almirall was founded in 1944.
-
Where is Almirall headquartered?
Almirall is headquartered in Barcelona, Spain.
-
What is the size of Almirall?
Almirall has 2,097 total employees.
-
What industry is Almirall in?
Almirall’s primary industry is Pharmaceuticals.
-
Is Almirall a private or public company?
Almirall is a Public company.
-
What is Almirall’s stock symbol?
The ticker symbol for Almirall is ALM.
-
What is the current stock price of Almirall?
As of 13-Nov-2026 the stock price of Almirall is $11.80.
-
What is the current market cap of Almirall?
The current market capitalization of Almirall is $2.57B.
-
What is Almirall’s current revenue?
The trailing twelve month revenue for Almirall is $1.65B.
-
Who are Almirall’s competitors?
Evonile Pharma, Assertio Holdings, Chiesi Farmaceutici, Grifols, and GSK are some of the 35 competitors of Almirall.
-
What is Almirall’s annual earnings per share (EPS)?
Almirall’s EPS for 12 months was $0.39.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
